Longitudinal in vivo monitoring of callus remodeling in BMP‐7‐ and Zoledronate‐treated fractures
Open Access
- 19 February 2020
- journal article
- research article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 38 (9) , 1905-1913
Abstract
Pharmacological interventions which combine pro‐anabolic and anti‐catabolic drugs to treat recalcitrant fractures have shown remarkable efficacy in augmenting the regenerative response. Specifically, in rodent models of fracture repair, treatment with BMP‐7 and Zoledronate (ZA) has almost uniformally resulted in complete union. However, delayed remodelling may be problematic for ZA treated fractures. The increase in newly formed bone is substantial but if translated in humans, delayed remodelling may delay functional recovery. Our objective was to determine if, and to what the extent, BMP in synergistically administered BMP‐7 + ZA can modulate the delayed hard callus remodelling caused by ZA. Callus remodelling in BMP‐7‐only and BMP‐7 + ZA treated osteotomies were monitored using in vivo µCT to follow the progression of healing at 6‐week intervals over 24 weeks in an open femoral fracture rat model. None of the groups recovered baseline cortical bone volumes within 24 weeks post‐osteotomy. Treatment prolonged the remodelling phase but the kinetics of remodelling appeared to differ between BMP and BMP + ZA groups. However, the mechanical characteristics were largely restored. Callus/bone volumes in BMP‐only treated fractures peaked as early as week 3 suggesting remodelling is stimulated prematurely. However, this rate of remodelling was not maintained as BMP‐7 was found to exhibit negligible changes in callus/bone volumes between weeks 6 – 18, whereas declines in callus/bone volumes were present at these time points in the BMP‐7 + ZA group. Our findings suggest that inclusion of ZA as an anti‐catabolic agent may not be detrimental to the regenerative process despite of a prolonged remodelling phase.Keywords
Funding Information
- Greta och Johan Kocks stiftelser
- Crafoordska Stiftelsen
- VINNOVA
- European Commission (FRACQUAL‐293434)
This publication has 24 references indexed in Scilit:
- Do osteoporotic fractures constitute a greater recalcitrant challenge for skeletal regeneration? Investigating the efficacy of BMP-7 and zoledronate treatment of diaphyseal fractures in an open fracture osteoporotic rat modelOsteoporosis International, 2016
- Investigating the synergistic efficacy of BMP-7 and zoledronate on bone allografts using an open rat osteotomy modelBone, 2013
- Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorptionSeminars in Cell & Developmental Biology, 2008
- Bone remodeling during fracture repair: The cellular pictureSeminars in Cell & Developmental Biology, 2008
- Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidenceOsteoporosis International, 2007
- BONE MORPHOGENETIC PROTEINS IN CLINICAL APPLICATIONSAnz Journal of Surgery, 2007
- The anabolic and catabolic responses in bone repairThe Journal of Bone and Joint Surgery. British volume, 2007
- Manipulation of the Anabolic and Catabolic Responses With OP-1 and Zoledronic Acid in a Rat Critical Defect ModelJournal of Bone and Mineral Research, 2005
- BMP Signaling in Osteogenesis, Bone Remodeling and RepairEuropean Journal of Trauma, 2005
- OSTEOGENIC ACTIVITY OF THE FOURTEEN TYPES OF HUMAN BONE MORPHOGENETIC PROTEINS (BMPS)Journal of Bone and Joint Surgery, 2003